Literature DB >> 8825115

Seroprevalence of HIV and HCV infections in Alexandria, Egypt.

I Quinti1, E Renganathan, E El Ghazzawi, M Divizia, G Sawaf, S Awad, A Pana, G Rocchi.   

Abstract

During the years 1992-1994, we tested 948 individuals from different population groups for HIV-1 and HIV-2 infections by ELISA and WB and for HCV infection by ELISA. Repeated ELISA reactivity for HIV was found in 2.12% of blood donors, 2.95% of fire brigade personnel and 1.61% of prisoners. Western blotting studies, however, showed that these samples were non-reactive or indeterminate to either HIV-1 or HIV-2. In contrast, anti-HCV antibodies were detected in 39% of fire brigade personnel, 31.4% of prisoners and 20.8% of blood donors. The analysis of risk factors for acquiring HCV infection showed a strong association between a past history of parenteral therapy for schistosomiasis and anti-HCV seropositivity (p < 0.0001). The implementation of preventive strategies is at the moment the mandatory choice to stop a further spread of the HCV infection. Meanwhile the same preventive measures could avoid spreading of the HIV disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8825115     DOI: 10.1016/s0934-8840(11)80205-7

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  7 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward.

Authors:  Ayman El Garf; Bassel El Zorkany; Rasha Gheith; Hala Sheba; Geilan Abdel Moneim; Kamal El Garf
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

3.  HCV infection in Egyptian patients with acute hepatitis.

Authors:  I Quinti; D el-Salman; M K Monier; B G Hackbart; M S Darwish; D el-Zamiaty; R Paganelli; F Pandolfi; R R Arthur
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

4.  Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluation.

Authors:  F DeWolfe Miller; Mahmoud S Elzalabany; Sara Hassani; Diego F Cuadros
Journal:  World J Hepatol       Date:  2015-12-08

Review 5.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

Review 6.  Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.

Authors:  Marieke Heijnen; Ghina R Mumtaz; Laith J Abu-Raddad
Journal:  J Int AIDS Soc       Date:  2016-05-27       Impact factor: 5.396

Review 7.  Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions.

Authors:  Silva P Kouyoumjian; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.